2 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Pregnancy: new trials by email Literature Review of Pregnancy trials Research Report on Pregnancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection Mefloquine Artesunate - Malaria, Pregnancy | Phase 2 / Phase 3 | Withdrawn | Centers for Disease Control and Prevention | 2010-03-01 | 2012-04-13 | |
| Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial Efavirenz-Tenofovir-Emtricitabine, Zidovudine-Lamivudine-Lopinavir/Ritonavir - HIV Infection, Pregnancy | Phase 3 | Withdrawn | French National Agency for Research on AIDS and Viral Hepatitis | 2010-01-01 | 2012-02-15 |
Breast Feeding (1) · HIV Infections (1) · Malaria (1)
Infections (2) · Behavior (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Feeding Behavior (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Lentivirus Infections (1) · Mosquito-Borne Diseases (1) · Parasitic Diseases (1) · Protozoan Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1)
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Ritonavir (1)
Centers for Disease Control and Prevention (1) · French National Agency for Research on AIDS and Viral Hepatitis (1)
Côte d’Ivoire (1) · Zambia (1)